Results 241 to 250 of about 2,832,778 (342)

Re-evaluation of oxygen (E 948) and hydrogen (E 949) as food additives. [PDF]

EFSA J
EFSA Panel on Food Additives and Flavourings (FAF), Castle L, Andreassen M, Aquilina G, Bastos ML, Boon P, Fallico B, FitzGerald R, Frutos Fernandez MJ, Grasl-Kraupp B, Gundert-Remy U, Gürtler R, Houdeau E, Kurek M, Louro H, Morales P, Passamonti S, Rasinger JD, Smeraldi C, Di Ciano S, Dino B, Mazzoli E, Rincon AM.   +22 more
europepmc   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Engaging medical and dental students in curriculum committees: Faculty insights and expectations. [PDF]

Pak J Med Sci
Mahmood A, Amin S, Mahboob U, Khan NA.
europepmc   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

AI-Enhanced Conversational Agents for Personalized Asthma Support in People With Asthma: Factors for Engagement, Value, and Efficacy in a Cross-Sectional Survey Study.

JMIR Hum Factors
Moradbakhti L, Peters D, Quint JK, Schuller B, Cook D, Calvo RA.   +5 more
europepmc   +1 more source

National bitterness, powerlessness and greatness: Examining constructions of affect as part of argumentation in populist EU discourse in Finland. [PDF]

Br J Soc Psychol
Tormis H, Sakki I, Pettersson K.
europepmc   +1 more source

Through the lens of marketing authorization holders: experience in use of real‐world data and real‐world evidence in drug development and regulatory submissions in EU

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola, Aleksandar Gigov, Hubertus G. M. Leufkens, Andrew Bate, Marie Louise De Bruin, Helga Gardarsdottir   +5 more
wiley   +1 more source

A Measurement Gap? Effect of Survey Instrument and Scoring on the Partisan Knowledge Gap. [PDF]

Public Opin Q
Shen L, Sood G, Weitzel D.
europepmc   +1 more source

Bulk Ingestion of Congressional Actions and Materials Dataset. [PDF]

Sci Data
Delano R, Rudkin A, Kim IS.
europepmc   +1 more source

Participation Beyond Compliance: Who Tried to Influence Other People's Vaccination Behaviour During the COVID-19 Crisis? [PDF]

Sociol Health Illn
Touzet H, Giry B, Ward JK.
europepmc   +1 more source